Disposition of 30000 shares by Kaushal Nitin of Viemed Healthcare at 2.5 subject to Rule 16b-3
| 50249AAF0 | 91.30 5.75 5.92% |
About 62% of 50249AAF0's investor base is looking to short. The analysis of the overall prospects from investing in LYB 125 01 OCT 25 suggests that many traders are, at the present time, alarmed. The current market sentiment, together with 50249AAF0's historical and current headlines, can help investors time the market. In addition, many technical investors use LYB 125 01 bond news signals to limit their universe of possible portfolio assets.
50249AAF0 |
Filed transaction by Viemed Healthcare Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at investing.com
 |
LYB 125 01 Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 50249AAF0 bond to make a market-neutral strategy. Peer analysis of 50249AAF0 could also be used in its relative valuation, which is a method of valuing 50249AAF0 by comparing valuation metrics with similar companies.
Peers
50249AAF0 Related Equities
| MX | MagnaChip Semiconductor | 3.41 | ||||
| UBER | Uber Technologies | 0.08 | ||||
| MCHP | Microchip Technology | 0.79 | ||||
| CDNS | Cadence Design | 1.75 | ||||
| MTSI | MACOM Technology | 2.21 | ||||
| QTWO | Q2 Holdings | 2.34 | ||||
| ASX | ASE Industrial | 2.77 | ||||
| MU | Micron Technology | 3.54 |
Other Information on Investing in 50249AAF0 Bond
50249AAF0 financial ratios help investors to determine whether 50249AAF0 Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 50249AAF0 with respect to the benefits of owning 50249AAF0 security.